Perrigo Company plc Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
Perrigo Company plc (PRGO) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2014-06-28, per its 10-K filed 2014-08-14.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2014-08-14
- Perrigo Company plc income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2014 was $0.00.
- Perrigo Company plc income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Perrigo Company plc income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2012 was $0.09.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|
| 2014-06-28 | $0.00 10-K · filed 2014-08-14 |
| 2013-06-29 | $0.00 10-K · filed 2014-08-14 |
| 2012-06-30 | $0.09 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |